You just read:

Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths

News provided by

U.S. Food and Drug Administration

Jan 17, 2019, 10:32 ET